What this effectively means is no more CRs or maybe one next...

What this effectively means is no more CRs or maybe one next July. 1.8m now, that covers Navua and US marketing. We have money in the bank and growing sales to cover us up to the conversion of options by the 31st March. Let's say $1.5m get converted and $1.5m in piggyback options by next December. And then $4.6m by June 2026. Sophisticated investors are all over this, the Asian market seems hot for Kava. If we get another CR next July it will be a Rights Issue IMO, for all to participate in, but most likely that will also be scaled back.

Possible catalysts include huge growth in the US. Relaxed regulatory controls in Australia and Europe. We are expanding 3x are production rate of green kava (we are currently at maximum), taking our revenue stream up to a potential of $30m a year. profit in 2025. Supply chain, best in the world, capable of gearing up. new management format with a US GM and Australia GM, next year, Noble to stay on in exec management team, which is very encouraging. Zane once again in control of his baby, he now has a lean business model working from the ground up with international appeal both from investors and consumers, and soon traceability. He just needs to do what he does best and sell Kava to the world.

This is largely a buy on market play now for new investors. I will need to buy some on market to avoid dilution, but happy to do so. I have the valuation of this company somewhere at $100m - $150m, so dilution for asset purchase and growth is not dilutionary in general.